Literature DB >> 101149

Characterization of lysosomal hydrolases that are elevated in Gaucher's disease.

K D Moffitt, J P Chambers, W F Diven, R H Glew, D A Wenger, D F Farrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 101149     DOI： 10.1016/0003-9861(78)90274-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN： 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  5 in total

Review 1.  Are there useful biochemical markers of disease activity in lysosomal storage diseases?

Authors:  B Winchester
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  CSF lysosomal hydrolase activity as an aid in the diagnosis of bacterial meningitis.

Authors:  W F Diven; R H Glew; J C Ihongbe; J Omene
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

3.  Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures.

Authors:  I Gery; J S Zigler; R O Brady; J A Barranger
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

4.  Elevation of serum beta-hexosaminidase and alpha-D-mannosidase in type 2 Gaucher disease: a clinical and biochemical study.

Authors:  D Chitayat; S Nakagawa; R W Marion; G S Sachs; S Shinnar; J F Llena; H M Nitowsky
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.

Authors:  Alisdair McNeill; Joana Magalhaes; Chengguo Shen; Kai-Yin Chau; Derralyn Hughes; Atul Mehta; Tom Foltynie; J Mark Cooper; Andrey Y Abramov; Matthew Gegg; Anthony H V Schapira
Journal:  Brain       Date:  2014-02-25       Impact factor: 13.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.